Play

People with cancer who enroll in clinical trials do better. That wisdom appears to have been dashed with results of a new study showing no survival benefit or any other positive outcome related to clinical trial participation. Johns Hopkins Kimmel …

Should you participate in a clinical trial if you have cancer? Elizabeth Tracey reports Read more »

Play

Cancer of the esophagus can be challenging to treat, and when it’s diagnosed a number of studies are appropriate to fully evaluate the disease. That’s according to Richard Battafarano, director of thoracic surgery at Johns Hopkins. Battafarano: Undergoing endoscopic ultrasound …

A range of tests should accompany evaluation for esophagus cancer, Elizabeth Tracey reports Read more »

Play

Esophagus cancer awareness month has just ended, and Richard Battafarano, director of thoracic surgery at Johns Hopkins, says while some people may have this type of cancer and not know it, the majority will have a range of symptoms. Battafarano: …

What are the symptoms of cancer of the esophagus? Elizabeth Tracey reports Read more »

Play

Bladder cancer treatment is about to change dramatically based on a trial showing that adding an antibody to a toxic substance is much more effective than current treatments. Johns Hopkins Kimmel Cancer director William Nelson describes this class of pharmaceuticals. …

A new type of pharmaceutical to treat bladder cancer may become the method of choice, Elizabeth Tracey reports Read more »

Play

Stool based tests to screen for colorectal cancer have been around for some time and work pretty well. Now one of the most utilized ones has been improved, a clinical trial shows. William Nelson, director of the Kimmel Cancer Center …

A stool based test for colorectal cancer just got an update, Elizabeth Tracey reports Read more »

Play

A blood test to screen for cancer is something of a Holy Grail, and now a new study describes one for colorectal cancer. Kimmel Cancer Center director William Nelson at Johns Hopkins says while there is still quite a bit …

Is a better way to screen for colorectal cancer on the horizon? Elizabeth Tracey reports Read more »

Play

Myc, ras, BRCA…these are all shorthand for common cancer mutations, with a new study saying that’s how cancers should be identified rather than which organ or system they’re found in, since not knowing the mutations may delay proper treatment. Kimmel …

Should cancers be named according to which mutations they carry? Elizabeth Tracey reports Read more »